MassMutual Private Wealth & Trust’s Tarsus Pharmaceuticals TARS Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio TARS Stock Details TARS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7.47K	Sell	95 -15	-14%	-$1.04K	﹤0.01%	1456
2026 Q2	$6.92K	Hold	110	–	–	﹤0.01%	1560
2026 Q1	$7.72K	Hold	110	–	–	﹤0.01%	1479
2025 Q4	$9.01K	Sell	110 -26	-19%	-$1.94K	﹤0.01%	1433
2025 Q3	$8.08K	Sell	136 -44	-24%	-$2.17K	﹤0.01%	1478
2025 Q2	$7.29K	Sell	180 -30	-14%	-$1.35K	﹤0.01%	1484
2025 Q1	$10.8K	Buy	+210	New	+$10.4K	﹤0.01%	1283
2023 Q2	–	Sell	-95	Closed	-$1.19K	–	2013
2023 Q1	$1.19K	Hold	95	–	–	﹤0.01%	1551
2022 Q4	$1K	Buy	95 +72	+313%	+$1.19K	﹤0.01%	1551
2022 Q3	$0	Buy	+23	New	+$365	﹤0.01%	1810

Other funds holding TARS

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

MassMutual Private Wealth & Trust's TARS Position: Q3 2026 in Review

MassMutual Private Wealth & Trust reduced its Tarsus Pharmaceuticals (TARS) stake by 14% in Q3 2026, selling an estimated $1.04K and leaving 95 shares worth $7.47K. The position accounts for ﹤0.01% of the portfolio, ranked #1456.

MassMutual Private Wealth & Trust first reported a position in TARS in Q3 2022 and has held it in 10 quarters since. The position peaked at $10.8K in Q1 2025. 108 funds tracked by Wall St. Rank hold TARS as of Q3 2026.

MassMutual Private Wealth & Trust held 95 shares of Tarsus Pharmaceuticals worth $7.47K as of Q3 2026.
MassMutual Private Wealth & Trust sold 15 Tarsus Pharmaceuticals shares in Q3 2026, an estimated $1.04K.
Tarsus Pharmaceuticals made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #1456 holding.
MassMutual Private Wealth & Trust first reported a position in Tarsus Pharmaceuticals in Q3 2022 and has held it in 10 quarters since.
MassMutual Private Wealth & Trust's Tarsus Pharmaceuticals position peaked at $10.8K in Q1 2025.
108 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.